Adult Liver Carcinoma — Trials

Adult Liver Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

67 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 17.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11)

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04497038	Cabozantinib in Patients With Advanced Hepatocellular Carcinoma With Child Pugh Class B Cirrhosis After First-Line Therapy	terminated	Phase 1 / Phase 2	3	University of Michigan Rogel Cancer CenterOTHER	1	Aug 6, 2024	clinicaltrials
NCT00459108	Dasatinib in Treating Patients With Advanced Liver Cancer That Cannot Be Removed by Surgery	terminated	Phase 2	25	National Cancer Institute (NCI)NIH	1	Apr 19, 2018